Form 4: Humana Executive Reports Stock Transactions

Humana Inc. Chief Legal Officer Joseph C. Ventura reported a significant acquisition of company stock on May 1, 2026, alongside details of his existing derivative holdings.

Summary

• Joseph C. Ventura, Chief Legal Officer of Humana Inc., reported the acquisition of 10,318 shares of Humana Common stock on May 1, 2026.
• The acquisition was valued at $0, indicating it was likely a grant or award.
• Following this transaction, Ventura beneficially owns 27,405 shares of Humana Common stock directly.
• The filing also details Ventura's holdings in various stock options granted under the company's 2019 Amended & Restated Stock Incentive Plan, with exercise prices ranging from $350.7875 to $510.2425.
• These options have vesting dates extending through February 2030.
• Additionally, the filing notes 16,568 restricted stock units (RSUs) held for contingent rights to receive Humana Inc. common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it solely reports on insider stock transactions and holdings without providing performance data or strategic updates.

Positives

• Acquisition of 10,318 Humana Common shares by the Chief Legal Officer, indicating continued investment and confidence in the company.
• Significant holdings in stock options and restricted stock units suggest long-term incentive alignment between management and shareholders.
• The transaction date of May 1, 2026, is clearly documented.

Negatives

• The filing is a Form 4, which reports changes in beneficial ownership and does not inherently contain negative financial performance indicators.
• No specific financial metrics or performance data are presented in this type of filing.

Risks

• The value of the acquired shares and outstanding options is subject to market fluctuations and the future performance of Humana Inc.
• Vesting schedules for options and RSUs mean that the full benefit is realized over time, subject to continued employment and company performance.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports on past transactions and current holdings.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions in the healthcare and insurance industry, reflecting executive compensation structures and personal investment decisions.

Stakeholder Impact

• Shareholders: The acquisition by a key executive may be viewed positively, signaling confidence, but the overall impact is minimal without further context on company performance.
• Employees: The executive's compensation structure, including options and RSUs, is typical and generally understood within corporate environments.
• Creditors: No direct impact from this type of filing.

Next Steps

• Continued monitoring of Joseph C. Ventura's beneficial ownership for any future transactions.
• Tracking the vesting and potential exercise of outstanding stock options and RSUs.

Key Dates

Keywords

Humana Inc., HUM, Form 4, Stock Transaction, Beneficial Ownership, Joseph C. Ventura, Chief Legal Officer, Stock Options, Restricted Stock Units, SEC Filing